CSF1R and neoplasm: Given, the pro-tumor role of macrophages following RT multiple groups have shown that blocking macrophage recruitment via targeting CD11b (16), CCL2 (81), or CSF-1R (4, 75, 100), enhance the efficacy of RT in preclinical murine models.